Deutsch English Français

Contact

EP3339328

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3339328

EP3339328 - ANTI-BIOTIN ANTIBODIES AND METHODS OF USE [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 21.03.2020 Database last updated on 20.09.2024
Former	Request for examination was made Status updated on 18.01.2019
Former	The application has been published Status updated on 25.05.2018
Most recent event Tooltip	24.07.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
	[2018/26]
Inventor(s)	01 / BRINKMANN, Ulrich c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE
	02 / GEORGES, Guy c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE
	03 / GROTE, Michael c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE
	04 / HOFFMANN, Eike c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE
	[2018/26]
Representative(s)	Burger, Alexander, et al Roche Diagnostics GmbH Patentabteilung Nonnenwald 2 82377 Penzberg / DE
	[N/P]
Former [2018/26]	Burger, Alexander, et al Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52 82372 Penzberg / DE
Application number, filing date	18150996.9	04.07.2013
	[2018/26]
Priority number, date	EP20120174957	04.07.2012 Original published format: EP 12174957
	[2018/26]
Previously filed application, date	WO2013EP64099	04.07.2013
	[2018/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3339328
	Date:	27.06.2018
	Language:	EN
	[2018/26]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	20.03.2018
Classification	IPC:	C07K16/44	[2018/26]
	CPC:	C07K16/44 (EP,KR,RU,US); A61K47/6801 (KR,US); A61K47/6835 (EP,US); C07K2299/00 (EP,KR,RU,US); C07K2317/24 (EP,KR,RU,US); C07K2317/31 (KR,US); (+) C07K2317/55 (EP,KR,RU,US); C07K2317/56 (US); C07K2317/565 (EP,KR,US); C07K2317/92 (EP,KR,RU,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/08]
Former [2018/26]	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Title	German:	ANTI-BIOTIN-ANTIKÖRPER UND VERWENDUNGSVERFAHREN	[2018/26]
	English:	ANTI-BIOTIN ANTIBODIES AND METHODS OF USE	[2018/26]
	French:	ANTICORPS ANTI-BIOTINE ET PROCÉDÉS D'UTILISATION	[2018/26]
Examination procedure	02.01.2019	Examination requested [2019/08]
	02.01.2019	Date on which the examining division has become responsible
	24.04.2019	Amendment by applicant (claims and/or description)
	25.03.2020	Despatch of a communication from the examining division (Time limit: M06)
	27.10.2020	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	06.01.2021	Reply to a communication from the examining division
	27.08.2021	Despatch of a communication from the examining division (Time limit: M06)
	23.02.2022	Reply to a communication from the examining division
	10.01.2024	Despatch of a communication from the examining division (Time limit: M04)
	18.03.2024	Reply to a communication from the examining division
Parent application(s) Tooltip	EP13734999.9 / EP2870180
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	11.01.2021	Request for further processing filed
	11.01.2021	Full payment received (date of receipt of payment) Request granted
	22.01.2021	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	24.04.2019	Request for further processing filed
	24.04.2019	Full payment received (date of receipt of payment) Request granted
	08.05.2019	Decision despatched
Fees paid	Renewal fee
	11.05.2018	Renewal fee patent year 03
	11.05.2018	Renewal fee patent year 04
	11.05.2018	Renewal fee patent year 05
	10.07.2018	Renewal fee patent year 06
	09.07.2019	Renewal fee patent year 07
	10.07.2020	Renewal fee patent year 08
	12.07.2021	Renewal fee patent year 09
	11.07.2022	Renewal fee patent year 10
	20.07.2023	Renewal fee patent year 11
	23.07.2024	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[YD]WO0050088 (MILLENNIUM PHARM INC [US]);
		[YD]WO0134651 (KS BIOMEDIX LTD [GB], et al);

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p